Brian Isherwood

Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada.

Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities.

DRM Ventures, Inc. provides investment services. The company was founded on August 24, 2009 and is headquartered in Toronto, Canada.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF).

DuMoulin Black LLP operates as a corporate finance and securities law firm. It practices in the areas of mergers and acquisitions, proxy contests, corporate governance and corporate law. The company was founded in 1966 and is headquartered in Vancouver, Canada.

Part of iA Financial Corp., Inc., Vengate Capital Partners is a Canadian company that provides financial advisory services to life and science companies. The company is based in Toronto, Canada. Vengate Capital Partners was acquired by MGI Securities, Inc. on November 03, 2004.

Amadeus International, Inc. operates as a development stage company. It focuses on the marketing of software solutions, such as enterprise quality resource planning, and enterprise quality & compliance management. The company was founded on December 22, 2004 and is headquartered in Quebec, Canada.

Founded in 1988, Beacon Securities Ltd. is an independent investment dealer located in Halifax, Nova Scotia. The firm specializes in research, underwriting, trading and sales. Their research focuses on companies with a connection to Atlantic Canada and with income trusts, both in Atlantic Canada and throughout Canada. Beacon's fixed-income team is involved in underwriting, origination, trading and sales. They have significant expertise in the Canadian fixed-income market with a focus on Eastern Canadian provincial, municipal and corporate debt.

PricewaterhouseCoopers LLP provides accounting services. The firm provides industry focused assurance, advisory and tax services for public, private and government clients in four areas such as corporate accountability, risk management, structuring and mergers and acquisitions and performance and process improvement. Its services include consulting, deals, risk assurance services and insolvency assignments. The company was founded on July 1, 1998 and is headquartered in Toronto, Canada.

The Canadian Bar Association operates as a professional organization. The non-profit company is based in Ottawa, Canada. and has subsidiaries in Canada.

British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada.

Tennis British Columbia develops and delivers tennis programs. It provides youth and adult tennis, coaching, and tournaments. The company is headquartered in Vancouver, Canada.

Draganfly Innovations, Inc. manufactures multi-rotor helicopters. Its products include Draganflyer Guardian, Draganflyer X4-P, Draganflyer Commander, Draganfly Tango2, Draganfly DraganScout, Draganfly UCS and Payload Integration. The firm offers aerial mapping, industrial imaging, agricultural and aerial photography services. The company was founded by Christine Dragan, Cameron Chell, Robert Kennedy and Zenon Dragon in 1998 and is headquartered in Saskatoon, Canada.

Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada.

ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.

Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.